Literature DB >> 8287939

Airway inflammation in symptomatic and asymptomatic children with methacholine hyperresponsiveness.

I Pin1, S Radford, R Kolendowicz, B Jennings, J A Denburg, F E Hargreave, J Dolovich.   

Abstract

A definition of asthma includes symptoms due to reversible airflow limitation and airway hyperresponsiveness. Characteristically, there is also airway inflammation. In children with methacholine airway hyperresponsiveness but no asthma symptoms, we examined whether there were features of asthmatic airway inflammation. Forty one children, aged 11-16 yrs, were studied. Thirteen asymptomatic children with methacholine airway hyperresponsiveness (provocative concentration producing a 20% fall in forced expiratory volume in one second (PC20) geometric mean of 3.35 (range 1.08-7.81) mg.ml-1) were compared with 13 currently symptomatic asthmatics with a similar PC20 of 1.91 (0.42-6.5) mg.ml-1 and 13 normal children with a normal PC20 of 52.4 (17.6 to > 64) mg.ml-1. Breathlessness experienced during a methacholine test was recognized to have occurred previously in 7 out of 13 asymptomatic children and all symptomatic children. Asymptomatic children had significantly more airway responses to hyperventilation with cold dry air (4 out of 13) than normal children (0 out of 13) but less than symptomatic children (11 out of 15). Sputum induced with hypertonic saline contained lower eosinophil counts in the asymptomatic children (median (interquartile range) 0.20 (0.59)%) than in the symptomatic children (1.70 (9.45)%), and not different from the normal children (0.15 (0.61)%). Budesonide, 400 micrograms b.i.d. improved respiratory symptoms, forced expiratory volume in one second (FEV1) and methacholine PC20 in symptomatic children, but this effect did not reach statistical significance in asymptomatic children. We conclude that symptomatic children are more likely to have evidence of asthmatic inflammation than asymptomatic children and this probably explains the symptom difference.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8287939

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  15 in total

Review 1.  Airway hyperresponsiveness in asthma: not just a matter of airway inflammation.

Authors:  V Brusasco; E Crimi; R Pellegrino
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

Review 2.  The role of inflammation in childhood asthma.

Authors:  F Chedevergne; M Le Bourgeois; J de Blic; P Scheinmann
Journal:  Arch Dis Child       Date:  2000-06       Impact factor: 3.791

3.  Different cutoff values of methacholine bronchial provocation test depending on age in children with asthma.

Authors:  Eun Lee; Young-Ho Kim; Seungbong Han; Song-I Yang; Young-Ho Jung; Ju-Hee Seo; Hyo-Bin Kim; So Yeon Lee; Ji-Won Kwon; Soo-Jong Hong
Journal:  World J Pediatr       Date:  2017-03-08       Impact factor: 2.764

4.  Mucosal pathophysiology and inflammatory changes in the late phase of the intestinal allergic reaction in the rat.

Authors:  P C Yang; M C Berin; L Yu; M H Perdue
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

5.  Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity.

Authors:  N M Wilson; P Bridge; A Spanevello; M Silverman
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

6.  Increased neutrophils and cytokines, TNF-alpha and IL-8, in induced sputum of non-asthmatic patients with chronic dry cough.

Authors:  A Jatakanon; U G Lalloo; S Lim; K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

7.  Inhaled fluticasone and salmeterol suppress eosinophilic airway inflammation in chronic obstructive pulmonary disease: relations with lung function and bronchodilator reversibility.

Authors:  Diahn-Warng Perng; Cheng-Che Wu; Kang-Cheng Su; Yu-Chin Lee; Reury-Perng Perng; Chi-Wei Tao
Journal:  Lung       Date:  2006 Jul-Aug       Impact factor: 2.584

8.  A randomised, placebo controlled trial of inhaled salbutamol and beclomethasone for recurrent cough.

Authors:  A B Chang; P D Phelan; J B Carlin; S M Sawyer; C F Robertson
Journal:  Arch Dis Child       Date:  1998-07       Impact factor: 3.791

9.  [Consensus statement on the evaluation and therapy of chronic cough in children].

Authors:  Angela Zacharasiewicz; Ernst Eber; Josef Riedler; Thomas Frischer
Journal:  Wien Klin Wochenschr       Date:  2014-06-12       Impact factor: 1.704

10.  Bronchial responsiveness and symptoms in 5-6 year old children: a comparison of a direct and indirect challenge.

Authors:  N M Wilson; P Bridge; M Silverman
Journal:  Thorax       Date:  1995-04       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.